Competition & Peer Data API & CSV Delivery

Oncologix Tech Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Oncologix Tech Inc (OCLG) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2015
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
25.02 %
Q1 2015
Net Margin
-42.52 %
Q1 2015

Key Findings: Oncologix Tech Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 5M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+7.3% annualized vs trailing 12 months).
  • Peer revenue share: Oncologix Tech Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

OCLG Sales vs. its Competitors, Q1 2015

Oncologix Tech Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/OCLG/competitors
https://api.csimarket.com/api/v1/companies/OCLG/relationships
https://api.csimarket.com/api/v1/companies/OCLG/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs 25.0% for Oncologix Tech Inc. Oncologix Tech Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Oncologix Tech Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Oncologix Tech Inc. No Yes Yes No
Similar Growth & Profitability (8) 50.00 % (4 of 8) 100.00 % (8 of 8) 100.00 % (8 of 8) 50.00 % (3 of 6)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q1 2015

100%market share
  • Oncologix Tech Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Oncologix Tech Inc and its 0 tracked competitors.

See Oncologix Tech Inc's full market share breakdown »

OCLG Stock Performance relative to its Competitors

OCLG Competitors (weighted) Percent change over the selected range

OCLG Stock Performance relative to Similar Growth & Profitability Competitors

OCLG Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range